Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE:002773)
China
· Delayed Price · Currency is CNY 25.52
-0.28 (-1.09%)
May 14, 2025, 2:45 PM CST
SHE:002773 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 4,557 | 4,451 | 3,957 | 3,388 | 3,605 | 3,294 | Upgrade
|
| Other Revenue | 1.49 | 1.49 | 0.63 | 0.64 | 0.19 | 1.27 | Upgrade
|
| Revenue | 4,559 | 4,453 | 3,957 | 3,389 | 3,605 | 3,295 | Upgrade
|
| Revenue Growth (YoY) | 9.44% | 12.51% | 16.77% | -6.00% | 9.40% | 1.17% | Upgrade
|
| Cost of Revenue | 479.78 | 469.43 | 438.84 | 391.66 | 355.66 | 330.22 | Upgrade
|
| Gross Profit | 4,079 | 3,983 | 3,519 | 2,997 | 3,250 | 2,965 | Upgrade
|
| Selling, General & Admin | 2,166 | 2,117 | 1,943 | 1,710 | 1,786 | 1,892 | Upgrade
|
| Research & Development | 610.17 | 579.71 | 421.68 | 374 | 1,008 | 1,676 | Upgrade
|
| Other Operating Expenses | 49.67 | 53.43 | 52.75 | 48.47 | 51.08 | 45.92 | Upgrade
|
| Operating Expenses | 2,826 | 2,751 | 2,418 | 2,133 | 2,843 | 3,613 | Upgrade
|
| Operating Income | 1,253 | 1,232 | 1,101 | 864.46 | 407 | -647.52 | Upgrade
|
| Interest Expense | - | - | - | - | - | -0.5 | Upgrade
|
| Interest & Investment Income | 110.28 | 110.18 | 97.53 | 83.14 | 61.55 | 59.97 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.16 | -0.16 | 0.16 | 0.34 | 0.12 | 2.24 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.31 | 0.81 | -1.39 | -0.65 | -0.94 | -0.58 | Upgrade
|
| EBT Excluding Unusual Items | 1,361 | 1,343 | 1,197 | 947.29 | 467.73 | -586.4 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -214.84 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -2.37 | -1.06 | -0.83 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.01 | 0.01 | 0.01 | - | - | - | Upgrade
|
| Asset Writedown | -0.59 | -1.14 | -0.52 | -0.24 | -0.67 | -2.4 | Upgrade
|
| Other Unusual Items | 11.5 | 11.5 | 38.26 | 83.25 | 141.19 | 69.28 | Upgrade
|
| Pretax Income | 1,369 | 1,353 | 1,234 | 1,030 | 393.42 | -519.51 | Upgrade
|
| Income Tax Expense | 167.2 | 175.53 | 202.79 | 164.49 | -27.66 | -249.66 | Upgrade
|
| Earnings From Continuing Operations | 1,202 | 1,177 | 1,031 | 865.81 | 421.08 | -269.85 | Upgrade
|
| Minority Interest in Earnings | 15.57 | 14.22 | 13.64 | 30.86 | 0 | - | Upgrade
|
| Net Income | 1,218 | 1,191 | 1,045 | 896.67 | 421.08 | -269.85 | Upgrade
|
| Net Income to Common | 1,218 | 1,191 | 1,045 | 896.67 | 421.08 | -269.85 | Upgrade
|
| Net Income Growth | 6.92% | 14.02% | 16.52% | 112.94% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 921 | 916 | 916 | 915 | 915 | 870 | Upgrade
|
| Shares Outstanding (Diluted) | 921 | 916 | 916 | 915 | 915 | 870 | Upgrade
|
| Shares Change (YoY) | 1.06% | -0.01% | 0.16% | -0.05% | 5.16% | -0.34% | Upgrade
|
| EPS (Basic) | 1.32 | 1.30 | 1.14 | 0.98 | 0.46 | -0.31 | Upgrade
|
| EPS (Diluted) | 1.32 | 1.30 | 1.14 | 0.98 | 0.46 | -0.31 | Upgrade
|
| EPS Growth | 5.79% | 14.04% | 16.33% | 113.04% | - | - | Upgrade
|
| Free Cash Flow | 1,284 | 1,252 | 1,080 | 569.95 | -75.3 | -348.53 | Upgrade
|
| Free Cash Flow Per Share | 1.39 | 1.37 | 1.18 | 0.62 | -0.08 | -0.40 | Upgrade
|
| Dividend Per Share | 0.600 | 0.600 | 0.380 | 0.150 | 0.100 | 0.100 | Upgrade
|
| Dividend Growth | 57.89% | 57.89% | 153.33% | 50.00% | - | -64.29% | Upgrade
|
| Gross Margin | 89.48% | 89.46% | 88.91% | 88.44% | 90.14% | 89.98% | Upgrade
|
| Operating Margin | 27.49% | 27.68% | 27.81% | 25.51% | 11.29% | -19.65% | Upgrade
|
| Profit Margin | 26.71% | 26.75% | 26.40% | 26.46% | 11.68% | -8.19% | Upgrade
|
| Free Cash Flow Margin | 28.18% | 28.13% | 27.28% | 16.82% | -2.09% | -10.58% | Upgrade
|
| EBITDA | 1,484 | 1,462 | 1,322 | 1,021 | 554.33 | -529.02 | Upgrade
|
| EBITDA Margin | 32.56% | 32.82% | 33.40% | 30.11% | 15.38% | -16.05% | Upgrade
|
| D&A For EBITDA | 231.18 | 229.14 | 221 | 156.12 | 147.33 | 118.5 | Upgrade
|
| EBIT | 1,253 | 1,232 | 1,101 | 864.46 | 407 | -647.52 | Upgrade
|
| EBIT Margin | 27.49% | 27.68% | 27.81% | 25.51% | 11.29% | -19.65% | Upgrade
|
| Effective Tax Rate | 12.21% | 12.98% | 16.43% | 15.96% | - | - | Upgrade
|
| Revenue as Reported | 4,559 | 4,453 | 3,957 | 3,389 | 3,605 | 3,295 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.